Neurogenic Inflammation and Cardiac Dysfunction Due to Hypomagnesemia
暂无分享,去创建一个
C. Spurney | W. Weglicki | I. Mak | J. Chmielinska | J. Kramer | M. I. Tejero-Taldo | A. Komarov | M. Iantorno | C. Tziros
[1] W. Weglicki,et al. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. , 2007, Magnesium research.
[2] T. Shea-Donohue,et al. Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function , 2007, Molecular and Cellular Biochemistry.
[3] W. Weglicki,et al. NMDA receptor blockade attenuates neutrophil activation and systemic oxidative stress induced by Mg‐deficiency in rats , 2007 .
[4] W. Weglicki,et al. Modulation of circulating substance P in Mg‐deficient (MgD) rats by NMDA receptor and neutral endopeptidase inhibitors , 2007 .
[5] W. Weglicki,et al. The nerve-heart connection in the pro-oxidant response to Mg-deficiency , 2006, Heart Failure Reviews.
[6] W. Weglicki,et al. N-Methyl-d-aspartate Receptor Blockade Inhibits Cardiac Inflammation in the Mg2+-Deficient Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.
[7] P. Poole‐Wilson,et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. , 2003, The American journal of cardiology.
[8] W. Weglicki,et al. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat. , 2003, Magnesium research.
[9] T. Phillips,et al. Dietary Magnesium Intake Influences Circulating Pro-Inflammatory Neuropeptide Levels and Loss of Myocardial Tolerance to Postischemic Stress , 2003, Experimental biology and medicine.
[10] R. Brook,et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase , 2003, Vascular medicine.
[11] J. Joseph,et al. Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells , 2002, The Journal of Biological Chemistry.
[12] D. Mann,et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. , 2001, The Journal of infectious diseases.
[13] Z. Ba,et al. The small intestine plays an important role in upregulating CGRP during sepsis. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[14] I. Nishimoto,et al. Hypomagnesemia in critically ill cancer patients: a prospective study of predictive factors. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[15] W. Weglicki,et al. The Role of Antioxidant Drugs in Oxidative Injury of Cardiovascular Tissue , 1999, Heart Failure Reviews.
[16] C. Glembotski,et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. , 1998, Journal of molecular and cellular cardiology.
[17] T. Phillips,et al. Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency – modulation by nitric oxide synthase inhibition , 1997, Molecular and Cellular Biochemistry.
[18] W. Weglicki,et al. Role of free radicals and substance P in magnesium deficiency. , 1996, Cardiovascular research.
[19] T. Phillips,et al. Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. , 1996, Magnesium research.
[20] C. Scudamore,et al. Basal secretion and anaphylactic release of rat mast cell protease-II (RMCP-II) from ex vivo perfused rat jejunum: translocation of RMCP-II into the gut lumen and its relation to mucosal histology. , 1995, Gut.
[21] V. Mišík,et al. Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat hearts: vitamin E affords protection. , 1994, Free radical biology & medicine.
[22] T. Phillips,et al. Cytokines, Neuropeptides, and Reperfusion Injury during Magnesium Deficiency a , 1994, Annals of the New York Academy of Sciences.
[23] T. Phillips,et al. Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. , 1994, Circulation research.
[24] S. Rennard,et al. Substance P increases neutrophil adhesion to bronchial epithelial cells. , 1994, Journal of immunology.
[25] T. Phillips,et al. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: Effects of substance P-receptor inhibition , 1994, Molecular and Cellular Biochemistry.
[26] P. Kubes,et al. Nitric oxide syni hesis inhibition induces leukocyte adhesion via superoxid and mast cells , 2004 .
[27] T. Phillips,et al. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. , 1992, The American journal of physiology.
[28] T. Phillips,et al. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin , 1992, Molecular and Cellular Biochemistry.
[29] K. Bost,et al. Substance P: a late-acting B lymphocyte differentiation cofactor. , 1992, The American journal of physiology.
[30] P. Hedqvist,et al. Nerve-induced tachykinin-mediated vasodilation in skeletal muscle is dependent on nitric oxide formation. , 1991, European journal of pharmacology.
[31] P. Mantyh. Substance P and the Inflammatory and Immune Response , 1991, Annals of the New York Academy of Sciences.
[32] J. Palmblad,et al. Substance P activates and modulates neutrophil oxidative metabolism and aggregation. , 1989, The Journal of rheumatology.
[33] M. Seelig. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion. , 1989, The American journal of cardiology.
[34] M. Soma,et al. Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. , 1988, Prostaglandins.
[35] P. Jynge,et al. Acquired magnesium deficiency and myocardial tolerance to ischemia. , 1987, Journal of the American College of Nutrition.
[36] J. Downey,et al. Magnesium deficiency and myocardial infarct size in the dog. , 1985, Journal of the American College of Cardiology.
[37] E. Goetzl,et al. Specific stimulation of human T lymphocytes by substance P. , 1983, Journal of immunology.
[38] H. Hartung,et al. Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. , 1983, European journal of pharmacology.
[39] M. Dewood,et al. Serum magnesium and copper levels in myocardial infarction , 1981, The American journal of the medical sciences.
[40] S. Leeman. Substance P and neurotensin: discovery, isolation, chemical characterization and physiological studies. , 1980, The Journal of experimental biology.
[41] R. Schwartz,et al. Blood and mast cell histamine levels in magnesium-deficient rats. , 1980, The Journal of nutrition.
[42] H. A. Heggtveit,et al. CARDIAC NECROSIS AND CALCIFICATION IN EXPERIMENTAL MAGNESIUM DEFICIENCY. A LIGHT AND ELECTRON MICROSCOPIC STUDY. , 1964, The American journal of pathology.
[43] W. Weglicki,et al. Magnesium deficiency stimulates angiogenesis in the rat heart , 2004 .
[44] T. Günther,et al. Pathobiochemical effects of graded magnesium deficiency in rats. , 1998, Zeitschrift fur Ernahrungswissenschaft.
[45] T. Phillips,et al. Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. , 1997, Journal of molecular and cellular cardiology.
[46] T. Phillips,et al. Role of Tissue and Circulating Substance P in Cardiovascular Injury Associated with Mg-Deficiency , 1996 .
[47] T. Phillips,et al. Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. , 1994, Annals of the New York Academy of Sciences.
[48] T. Mcintosh. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. , 1993, Journal of neurotrauma.
[49] W. Weglicki,et al. Antioxidants and the cardiomyopathy of Mg-deficiency. , 1992, The American journal of cardiovascular pathology.
[50] A. Dubey,et al. Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction. , 1989, Drugs.
[51] S. Bloom,et al. Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy. , 1989, The American journal of cardiovascular pathology.
[52] Y. Itokawa. Tissue minerals of magnesium-deficient rats with thiamine deficiency and excess. , 1987, Magnesium.
[53] W. Leary. Content of magnesium in drinking water and deaths from ischaemic heart disease in white South Africans. , 1986, Magnesium.
[54] Leary Wp. Content of magnesium in drinking water and deaths from ischaemic heart disease in white South Africans. , 1986 .
[55] B. Altura,et al. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. , 1985, Magnesium.
[56] M. Zabik,et al. Magnesium and calcium dietary intakes of the U.S. population. , 1985, Journal of the American College of Nutrition.
[57] M. Costa,et al. Neuropeptides contained in peripheral cardiovascular nerves. , 1984, Clinical and experimental hypertension. Part A, Theory and practice.
[58] J. Vormann,et al. Influence of decreased and increased magnesium supply on the cardiotoxic effects of epinephrine in rats. , 1983, Arzneimittel-Forschung.
[59] S. Punsar,et al. Drinking water quality and sudden death. Observations from West and East Finland. , 1978, Advances in cardiology.